Free Trial

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (FBT) Competitors

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation logo
GBX 1,511.40 +37.70 (+2.56%)
As of 05/1/2025 03:12 AM Eastern

FBT vs. PRSM, KAPE, TRST, KNOS, LTG, ATG, GBG, ALFA, IMO, and CER

Should you be buying First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation stock or one of its competitors? The main competitors of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation include Blue Prism Group (PRSM), Kape Technologies (KAPE), Trustpilot Group (TRST), Kainos Group (KNOS), Learning Technologies Group (LTG), Auction Technology Group (ATG), GB Group (GBG), Alfa Financial Software (ALFA), IMImobile (IMO), and Cerillion (CER). These companies are all part of the "software - application" industry.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation vs.

Blue Prism Group (LON:PRSM) and First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) are both small-cap computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, community ranking, dividends, media sentiment and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
Blue Prism GroupN/A N/A N/A
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation N/A N/A N/A

Blue Prism Group received 71 more outperform votes than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation when rated by MarketBeat users. Likewise, 69.08% of users gave Blue Prism Group an outperform vote while only 66.67% of users gave First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation an outperform vote.

CompanyUnderperformOutperform
Blue Prism GroupOutperform Votes
143
69.08%
Underperform Votes
64
30.92%
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationOutperform Votes
72
66.67%
Underperform Votes
36
33.33%

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation is trading at a lower price-to-earnings ratio than Blue Prism Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Blue Prism Group£167.30M0.00N/A-£53.80N/A
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/AN/AN/A-£1.10-1,374.00

In the previous week, Blue Prism Group's average media sentiment score of 0.00 equaled First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation'saverage media sentiment score.

Summary

Blue Prism Group beats First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation on 4 of the 5 factors compared between the two stocks.

Get First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation News Delivered to You Automatically

Sign up to receive the latest news and ratings for FBT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FBT vs. The Competition

MetricFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationSoftware IndustryComputer SectorLON Exchange
Market Cap£620.00M£5.17B£23.43B£2.56B
Dividend YieldN/A3.18%2.96%4.97%
P/E Ratio-1,374.0027.8442.35132.50
Price / SalesN/A257.382,105.70227,865.53
Price / Cash3.5416.7634.7228.11
Price / BookN/A9.366.184.54
Net IncomeN/A£63.25M£737.35M£5.84B
7 Day Performance2.50%1.62%1.23%2.70%
1 Month Performance-2.95%1.10%1.65%9.91%
1 Year Performance5.68%3.62%52,704.80%114.85%

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FBT
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
N/AGBX 1,511.40
+2.6%
N/A+7.0%£620.00MN/A-1,374.0020
PRSM
Blue Prism Group
N/AN/AN/AN/A£1.24B£167.30M-23.681,025High Trading Volume
KAPE
Kape Technologies
N/AN/AN/AN/A£1.22B£623.48M1,900.00850Gap Down
TRST
Trustpilot Group
1.751 of 5 stars
GBX 215.60
+2.6%
GBX 335
+55.4%
+19.7%£1.13B£222.55M71.47820
KNOS
Kainos Group
3.1764 of 5 stars
GBX 711.50
+1.4%
GBX 1,052.50
+47.9%
-23.0%£898.70M£383.18M18.642,953
LTG
Learning Technologies Group
N/AGBX 99.90
flat
GBX 90
-9.9%
+38.2%£792.10M£529.20M16.755,001
ATG
Auction Technology Group
0.6394 of 5 stars
GBX 570
+0.5%
GBX 680
+19.3%
+18.6%£704.15M£136.68M69.62396
GBG
GB Group
1.8748 of 5 stars
GBX 264.50
+2.7%
GBX 395
+49.3%
-14.5%£667.14M£276.95M-13.731,183
ALFA
Alfa Financial Software
N/AGBX 208.93
+1.2%
N/A+27.8%£625.70M£103.11M28.24475Analyst Forecast
IMO
IMImobile
N/AN/AN/AN/A£490.40M£164.04M123.755,300
CER
Cerillion
0.8414 of 5 stars
GBX 1,507.55
+1.9%
GBX 1,682.50
+11.6%
+9.5%£447.07M£41.39M31.78321Dividend Increase
High Trading Volume

Related Companies and Tools


This page (LON:FBT) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners